Europe Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Country and Growth Forecast, 2022 - 2028

The Europe Non-steroidal Anti-inflammatory Drugs Market would witness market growth of 5.3% CAGR during the forecast period (2022-2028).

As NSAID research, production, and marketing operations include a large number of market participants, they frequently develop organic and inorganic growth strategies to increase their market share.

The availability of a wide range of NSAID preparations is also anticipated to support growth. For example, Pfizer Inc.'s Ketorolac tromethamine is used to treat fairly intense acute pain that necessitates opioid analgesia. Additionally, the GSK Group of Companies' top company for relieving headaches is Excedrin, which combines caffeine, aspirin, and paracetamol. Over the projected period, it is expected that a strong market coverage of important brands and an increase in the launch of combination medications will fuel growth.

By the 2011 Five European Countries (5EU) National Health and Wellness Survey (NHWS), that comprised 57 512 respondents from Germany, France, Spain, Italy, and the UK, individuals with self-reported peripheral joint OA were chosen. 19% of adult Europeans experience chronic pain that ranges from mild to severe intensity, which has a significant impact on their social and professional lives. Probably half got subpar pain care, and only few were treated by pain experts. Even though there were disparities among the 16 nations, researchers have established that chronic pain is a significant issue in European healthcare that requires greater attention.

The Germany market dominated the Europe Non-steroidal Anti-inflammatory Drugs Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,663 Million by 2028. The UK market is anticipated to grow at a CAGR of 4.4% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 6% during (2022 - 2028).

Based on Route of Administration, the market is segmented into Oral, Topical and Others. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy and Online Pharmacy. Based on Route of Disease Indication, the market is segmented into Arthritis, Migraine, Ophthalmic Diseases and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Non-steroidal Anti-inflammatory Drugs Market will Hit $25.5 Billion by 2028, at a CAGR of 5.7%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Dr. Reddy’s Laboratories Ltd., Pfizer, Inc., GlaxoSmithKline PLC, Bayer AG, Teva Pharmaceuticals Industries Ltd., Eli Lilly And Company, Sanofi S.A., AstraZeneca PLC, Viatris, Inc., and Merck & Co., Inc.

Scope of the Study

Market Segments Covered in the Report:

By Route of Administration

• Oral
• Topical
• Others

By Distribution Channel

• Retail Pharmacy
• Hospital Pharmacy
• Online Pharmacy

By Disease Indication

• Arthritis
• Migraine
• Ophthalmic Diseases
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Dr. Reddy’s Laboratories Ltd.
• Pfizer, Inc.
• GlaxoSmithKline PLC
• Bayer AG
• Teva Pharmaceuticals Industries Ltd.
• Eli Lilly And Company
• Sanofi S.A.
• AstraZeneca PLC
• Viatris, Inc.
• Merck & Co., Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Non-steroidal Anti-inflammatory Drugs Market, by Route of Administration
1.4.2 Europe Non-steroidal Anti-inflammatory Drugs Market, by Distribution Channel
1.4.3 Europe Non-steroidal Anti-inflammatory Drugs Market, by Disease Indication
1.4.4 Europe Non-steroidal Anti-inflammatory Drugs Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Recent Strategies deployed in Non-steroidal Anti-inflammatory Drugs Market

Chapter 4. Europe Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
4.1 Europe Oral Market by Country
4.2 Europe Topical Market by Country
4.3 Europe Others Market by Country

Chapter 5. Europe Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
5.1 Europe Retail Pharmacy Market by Country
5.2 Europe Hospital Pharmacy Market by Country
5.3 Europe Online Pharmacy Market by Country

Chapter 6. Europe Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
6.1 Europe Arthritis Market by Country
6.2 Europe Migraine Market by Country
6.3 Europe Ophthalmic Diseases Market by Country
6.4 Europe Others Market by Country

Chapter 7. Europe Non-steroidal Anti-inflammatory Drugs Market by Country
7.1 Germany Non-steroidal Anti-inflammatory Drugs Market
7.1.1 Germany Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.1.2 Germany Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.1.3 Germany Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.2 UK Non-steroidal Anti-inflammatory Drugs Market
7.2.1 UK Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.2.2 UK Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.2.3 UK Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.3 France Non-steroidal Anti-inflammatory Drugs Market
7.3.1 France Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.3.2 France Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.3.3 France Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.4 Russia Non-steroidal Anti-inflammatory Drugs Market
7.4.1 Russia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.4.2 Russia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.4.3 Russia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.5 Spain Non-steroidal Anti-inflammatory Drugs Market
7.5.1 Spain Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.5.2 Spain Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.5.3 Spain Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.6 Italy Non-steroidal Anti-inflammatory Drugs Market
7.6.1 Italy Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.6.2 Italy Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.6.3 Italy Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.7 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market
7.7.1 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.7.2 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.7.3 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Disease Indication

Chapter 8. Company Profiles
8.1 Dr. Reddy’s Laboratories Ltd.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Approvals and Trails:
8.3 GlaxoSmithKline PLC
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals and Trails:
8.4 Bayer AG
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Approvals and Trails:
8.5 Teva Pharmaceutical Industries Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.6 Eli Lilly And Company
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Approvals and Trails:
8.7 Sanofi S.A.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.8 AstraZeneca PLC
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expenses
8.9 Viatris, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.10. Merck & Co., Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses

TABLE 1 Europe Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 2 Europe Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 3 Europe Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 4 Europe Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 5 Europe Oral Market by Country, 2018 - 2021, USD Million
TABLE 6 Europe Oral Market by Country, 2022 - 2028, USD Million
TABLE 7 Europe Topical Market by Country, 2018 - 2021, USD Million
TABLE 8 Europe Topical Market by Country, 2022 - 2028, USD Million
TABLE 9 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 12 Europe Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 13 Europe Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 15 Europe Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 16 Europe Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 17 Europe Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 18 Europe Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 19 Europe Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 20 Europe Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 21 Europe Arthritis Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe Arthritis Market by Country, 2022 - 2028, USD Million
TABLE 23 Europe Migraine Market by Country, 2018 - 2021, USD Million
TABLE 24 Europe Migraine Market by Country, 2022 - 2028, USD Million
TABLE 25 Europe Ophthalmic Diseases Market by Country, 2018 - 2021, USD Million
TABLE 26 Europe Ophthalmic Diseases Market by Country, 2022 - 2028, USD Million
TABLE 27 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 28 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 29 Europe Non-steroidal Anti-inflammatory Drugs Market by Country, 2018 - 2021, USD Million
TABLE 30 Europe Non-steroidal Anti-inflammatory Drugs Market by Country, 2022 - 2028, USD Million
TABLE 31 Germany Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 32 Germany Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 33 Germany Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 34 Germany Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 35 Germany Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 36 Germany Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 37 Germany Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 38 Germany Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 39 UK Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 40 UK Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 41 UK Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 42 UK Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 43 UK Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 44 UK Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 45 UK Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 46 UK Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 47 France Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 48 France Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 49 France Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 50 France Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 51 France Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 52 France Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 53 France Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 54 France Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 55 Russia Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 56 Russia Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 57 Russia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 58 Russia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 59 Russia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 60 Russia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 61 Russia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 62 Russia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 63 Spain Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 64 Spain Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 65 Spain Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 66 Spain Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 67 Spain Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 68 Spain Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 69 Spain Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 70 Spain Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 71 Italy Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 72 Italy Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 73 Italy Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 74 Italy Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 75 Italy Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 76 Italy Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 77 Italy Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 78 Italy Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 79 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 80 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 81 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 82 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 83 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 84 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 85 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 86 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 87 key information – Dr. Reddy’s Laboratories Ltd.
TABLE 88 Key Information – Pfizer, Inc.
TABLE 89 Key Information – GlaxoSmithKline PLC
TABLE 90 Key Information – Bayer AG
TABLE 91 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 92 Key Information – Eli Lilly And Company
TABLE 93 Key Information – Sanofi S.A.
TABLE 94 KEY INFORMATION – ASTRAZENECA PLC
TABLE 95 key information – Viatris, Inc.
TABLE 96 KEY INFORMATION - MERCK & CO., INC.

List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Dr. Reddy’s Laboratories Ltd.